区分帮助和伤害:辅助T细胞子集和与免疫相关的不良事件
Alexandra M Haugh1, Adil I Daud2
1Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
The Journal of clinical investigation
|October 15, 2024
概括
像IL-6这样的高细胞因子与接受免疫检查点抑制 (ICI) 的癌症患者的治疗结果和副作用更差有关. 向IL-6可能会改善治疗反应并降低毒性.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 翻译医学是一种翻译医学.
背景情况:
- 细胞因子在癌症的进展和对免疫治疗的反应中发挥着关键作用.
- 免疫检查点抑制 (ICI) 已经彻底改变了癌症治疗,但受到毒性和可变反应率的限制.
研究的目的:
- 研究在接受ICI治疗的固体瘤患者中T辅助细胞通路,细胞因子配置和结果之间的关系.
- 确定与免疫相关不良事件 (irAEs) 和治疗疗效相关的特定细胞因子.
主要方法:
- 在接受ICI的固体瘤患者中分析T细胞种群和细胞因子特征.
- 细胞因子水平与irrAEs的发生率和严重程度,客观反应率和生存结果的相关性.
- 评估患者病史,包括自身免疫性疾病,与irAE发展有关.
主要成果:
- 患有自身免疫性疾病史的患者有较高的irAEs发病率.
- 较高的IL-5,IL-6,IL-17f和TNF-α水平与2级或更高的irrAEs风险增加有关.
- 较高的IL-6水平与客观反应率的降低以及较差的癌症特异性和全因死亡率相关.
结论:
- 特定的细胞因子概况,特别是IL-6的升高,预测了irAEs和在接受ICI治疗固体瘤的患者中更糟糕的结果.
- 这些发现表明,向IL-6可能会提高ICI的疗效并减轻毒性.
- 对细胞因子驱动机制的进一步研究对于优化癌症免疫治疗策略至关重要.
相关概念视频
T Cell Types and Functions
959
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
959
Cell-mediated Immune Responses
67.5K
Overview
67.5K
T Cell Activation and Clonal Selection
679
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
679
Special Features of Adaptive Immunity
766
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
766
B Cell Activation and Differentiation
1.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.6K
Antigens Involved in Adaptive Immunity
465
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
465


